140 related articles for article (PubMed ID: 38393527)
1. Incidence, Risk Factors, and Prognosis of Patients with Hepatocellular Carcinoma and Brain Metastases.
Feng JC; He Y; Polychronidis G; Xin J; You S; Xiong J
Curr Med Sci; 2024 Feb; 44(1):180-186. PubMed ID: 38393527
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of a nomogram for hepatocellular carcinoma with brain metastasis at initial diagnosis: A population-based study.
Chen QF; Huang T; Shen L; Li W
PLoS One; 2019; 14(1):e0209293. PubMed ID: 30601858
[TBL] [Abstract][Full Text] [Related]
3. Impact of homogeneous and heterogeneous risk factors on the incidence and prognosis of brain metastases in patients with hepatocellular carcinoma.
Lin X; Zhang P; Huang R; Huang Y; Sun J; Zheng H; Tian X; Wang X
Ann Palliat Med; 2020 Sep; 9(5):2654-2667. PubMed ID: 32921091
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of Sites of Visceral Metastatic Disease in Prostate Cancer: A Population-based Study of 12,180 Patients.
Budnik J; Suri J; Bates JE; Bylund KC; Milano MT
Clin Genitourin Cancer; 2019 Aug; 17(4):260-267. PubMed ID: 31101579
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular Carcinoma Brain Metastases: A Single-Institution Experience.
Falkson SR; Bhambhvani HP; Hayden Gephart M
World Neurosurg; 2020 Aug; 140():e27-e32. PubMed ID: 32289508
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and risk differences of different tumor sizes on distant metastases of hepatocellular carcinoma: A retrospective cohort study in the SEER database.
Yan B; Bai DS; Zhang C; Qian JJ; Jin SJ; Jiang GQ
Int J Surg; 2020 Aug; 80():94-100. PubMed ID: 32619622
[TBL] [Abstract][Full Text] [Related]
7. Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based study.
De Toni EN; Schlesinger-Raab A; Fuchs M; Schepp W; Ehmer U; Geisler F; Ricke J; Paprottka P; Friess H; Werner J; Gerbes AL; Mayerle J; Engel J
Gut; 2020 Jan; 69(1):168-176. PubMed ID: 30878947
[TBL] [Abstract][Full Text] [Related]
8. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
Ding J; Wen Z
BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
[TBL] [Abstract][Full Text] [Related]
9. How do organ-specific metastases affect prognosis and surgical treatment for patients with metastatic upper tract urothelial carcinoma: first evidence from population based data.
Dong F; Fu H; Shi X; Shen Y; Xu T; Gao F; Wang X; Zhong S; Ding Q; Shen Z; Chen S
Clin Exp Metastasis; 2017 Dec; 34(8):467-477. PubMed ID: 29500709
[TBL] [Abstract][Full Text] [Related]
10. Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study.
Martin AM; Cagney DN; Catalano PJ; Warren LE; Bellon JR; Punglia RS; Claus EB; Lee EQ; Wen PY; Haas-Kogan DA; Alexander BM; Lin NU; Aizer AA
JAMA Oncol; 2017 Aug; 3(8):1069-1077. PubMed ID: 28301662
[TBL] [Abstract][Full Text] [Related]
11. The risk and prognostic factors for brain metastases in esophageal cancer patients: an analysis of the SEER database.
Cheng S; Yang L; Dai X; Wang J; Han X
BMC Cancer; 2021 Sep; 21(1):1057. PubMed ID: 34563149
[TBL] [Abstract][Full Text] [Related]
12. Advanced Hepatocellular Carcinoma with Bone Metastases: Prevalence, Associated Factors, and Survival Estimation.
Guo X; Xu Y; Wang X; Lin F; Wu H; Duan J; Xiong Y; Han X; Baklaushev VP; Xiong S; Chekhonin VP; Peltzer K; Wang G; Zhang C
Med Sci Monit; 2019 Feb; 25():1105-1112. PubMed ID: 30739123
[TBL] [Abstract][Full Text] [Related]
13. Brain metastases from hepatocellular carcinoma: clinical features and prognostic factors.
Jiang XB; Ke C; Zhang GH; Zhang XH; Sai K; Chen ZP; Mou YG
BMC Cancer; 2012 Feb; 12():49. PubMed ID: 22292912
[TBL] [Abstract][Full Text] [Related]
14. Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma.
Harding JJ; Abu-Zeinah G; Chou JF; Owen DH; Ly M; Lowery MA; Capanu M; Do R; Kemeny NE; O'Reilly EM; Saltz LB; Abou-Alfa GK
J Natl Compr Canc Netw; 2018 Jan; 16(1):50-58. PubMed ID: 29295881
[No Abstract] [Full Text] [Related]
15. Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma: a SEER database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mehrabi A; Schöb O; Giryes A; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2017 Jul; 11(7):695-701. PubMed ID: 28276812
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors of gastrointestinal neuroendocrine neoplasm metastasis in liver, lung, bone, and brain: A population-based study.
Zheng Z; Chen C; Jiang L; Zhou X; Dai X; Song Y; Li Y
Cancer Med; 2019 Dec; 8(17):7288-7298. PubMed ID: 31609098
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and prognosis of synchronous distant metastatic tonsil squamous cell carcinomas.
Li Y; Hu C
Int J Med Sci; 2021; 18(2):528-533. PubMed ID: 33390822
[TBL] [Abstract][Full Text] [Related]
18. Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma.
Rich NE; Murphy CC; Yopp AC; Tiro J; Marrero JA; Singal AG
Aliment Pharmacol Ther; 2020 Aug; 52(4):701-709. PubMed ID: 32598091
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of clinical characteristics on risk and prognosis of synchronous brain metastases in small-cell lung cancer patients: A population-based study.
Zhou G; Zhang Z; Yu P; Geng R; Wang G; Ma W; Gao J; Zheng Z; Li Y
Cancer Med; 2023 Jan; 12(2):1195-1203. PubMed ID: 35831985
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma.
Hu C; Yang J; Huang Z; Liu C; Lin Y; Tong Y; Fan Z; Chen B; Wang C; Zhao CL
BMC Cancer; 2020 Jun; 20(1):494. PubMed ID: 32487048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
